GSA Capital Partners LLP Purchases 6,676 Shares of Encompass Health Corporation $EHC

GSA Capital Partners LLP grew its position in shares of Encompass Health Corporation (NYSE:EHC) by 87.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,353 shares of the company’s stock after buying an additional 6,676 shares during the quarter. GSA Capital Partners LLP’s holdings in Encompass Health were worth $1,523,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in EHC. Royal Bank of Canada grew its stake in shares of Encompass Health by 21.5% during the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock valued at $8,960,000 after purchasing an additional 15,677 shares during the last quarter. Millennium Management LLC grew its stake in shares of Encompass Health by 38.4% during the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after purchasing an additional 25,574 shares during the last quarter. Caxton Associates LLP bought a new stake in shares of Encompass Health during the first quarter valued at approximately $259,000. Walleye Capital LLC grew its stake in shares of Encompass Health by 667.6% during the second quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock valued at $800,000 after purchasing an additional 7,671 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new stake in shares of Encompass Health during the second quarter valued at approximately $588,000. 97.25% of the stock is owned by institutional investors.

Encompass Health Trading Up 1.2%

Shares of NYSE EHC opened at $106.04 on Thursday. The company’s 50 day simple moving average is $102.82 and its 200 day simple moving average is $105.88. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The firm has a market capitalization of $10.52 billion, a P/E ratio of 17.70, a P/E/G ratio of 2.28 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.09. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. Encompass Health’s revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, analysts predict that Encompass Health Corporation will post 5.96 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 12.69%.

Analysts Set New Price Targets

Several analysts have recently commented on EHC shares. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. Barclays decreased their price target on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 5th. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and an average target price of $144.17.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the sale, the treasurer owned 89,325 shares in the company, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 1.80% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.